MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, PRME has $294,730K in assets. $218,030K in debts. $64,106K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
379.97%
Quick Ratio
379.97%
Cash Ratio
176.65%
Debt to Asset Ratio
73.98%
Unit: Thousand (K) dollars
Assets Breakdown
    • Operating lease right-of-use ass...
    • Cash and cash equivalents
    • Restricted cash
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liability, net o...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
64,106 63,032 71,396 53,804
Short-term investments-Nonrelated Party
-114,648 137,030 44,539
Short-term investments-Related Party
-0 4,861 3,407
Short-term investments
71,391 ---
Prepaid expenses
1,971 2,939 2,493 3,032
Collaboration receivable related party
---120
Other current assets
421 674 15,626 16,385
Total current assets
137,889 181,293 231,406 121,287
Property and equipment, net
18,816 20,572 22,046 23,828
Operating lease right-of-use assets
123,334 126,177 117,869 120,203
Restricted cash
13,691 13,691 13,691 13,691
Other assets
1,000 1,000 --
Total assets
294,730 342,733 385,012 279,009
Accounts payable
12,325 8,887 9,354 6,378
Accrued expenses and other current liabilities
8,098 12,600 11,000 12,158
Deferred revenue related party
7,320 7,824 6,951 8,315
Operating lease liability
8,546 8,137 7,714 7,258
Total current liabilities
36,289 37,448 35,019 34,109
Deferred revenue, net of current related party
57,775 58,127 59,751 59,562
Operating lease liability, net of current
105,966 108,290 110,421 112,478
Research and development funding liability
18,000 18,000 18,000 12,000
Total liabilities
218,030 221,865 223,191 218,149
Common stock, par value of 0.00001 per share 775,000,000 shares authorized 180,615,514 and 180,514,014 shares issued and outstanding as of march31, 2026 and december31, 2025, respectively
2 2 2 2
Additional paid-in capital
1,014,175 1,009,138 1,004,061 852,561
Accumulated other comprehensive (loss) income
-1 82 33 -10
Accumulated deficit
-937,476 -888,354 -842,275 -791,693
Total stockholders equity
76,700 120,868 161,821 60,860
Total liabilities and stockholders equity
294,730 342,733 385,012 279,009
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$71,391K Cash and cashequivalents$64,106K Prepaid expenses$1,971K Other current assets$421K Total current assets$137,889K Operating leaseright-of-use assets$123,334K Property and equipment,net$18,816K Restricted cash$13,691K Other assets$1,000K Total assets$294,730K Total liabilities andstockholders equity$294,730K Total liabilities$218,030K Total stockholdersequity$76,700K Accumulated deficit-$937,476K Accumulated othercomprehensive (loss) income-$1K Operating leaseliability, net of current$105,966K Deferred revenue, net ofcurrent related party$57,775K Total currentliabilities$36,289K Research and developmentfunding liability$18,000K Additional paid-in capital$1,014,175K Common stock, par valueof 0.00001 per...$2K Accounts payable$12,325K Operating lease liability$8,546K Accrued expenses andother current...$8,098K Deferred revenue relatedparty$7,320K

Prime Medicine, Inc. (PRME)

Prime Medicine, Inc. (PRME)